Individual radiation therapy patient whole-body phantoms for peripheral dose evaluations: method and specific software.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 19652292)

Published in Phys Med Biol on August 04, 2009

Authors

I Alziar1, G Bonniaud, D Couanet, J B Ruaud, C Vicente, G Giordana, O Ben-Harrath, J C Diaz, P Grandjean, H Kafrouni, J Chavaudra, D Lefkopoulos, F de Vathaire, I Diallo

Author Affiliations

1: U605 INSERM, Villejuif, France. IFR69, Villejuif, France. Université Paris XI, Villejuif, France. Institut Gustave-Roussy, Villejuif, France.

Articles by these authors

Male reproductive health and environmental xenoestrogens. Environ Health Perspect (1996) 4.11

Organochlorine exposure and risk of breast cancer. Lancet (1998) 3.18

Treatment of brain arteriovenous malformations by embolization and radiosurgery. J Neurosurg (1996) 3.12

Maternal seafood diet, methylmercury exposure, and neonatal neurologic function. J Pediatr (2000) 3.03

Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem (1997) 3.02

Correlation of the highest-energy cosmic rays with nearby extragalactic objects. Science (2007) 2.57

Evidence of behaviour change following a hygiene promotion programme in Burkina Faso. Bull World Health Organ (2001) 2.47

Structured observations of hygiene behaviours in Burkina Faso: validity, variability, and utility. Bull World Health Organ (1993) 2.19

Second primary malignancies in thyroid cancer patients. Br J Cancer (2003) 2.10

Potties, pits and pipes: explaining hygiene behaviour in Burkina Faso. Soc Sci Med (1995) 1.95

Confirmatory platelet-activating factor receptor antagonist trial in patients with severe gram-negative bacterial sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. BN 52021 Sepsis Investigator Group. Crit Care Med (1998) 1.94

Prenatal methylmercury exposure as a cardiovascular risk factor at seven years of age. Epidemiology (1999) 1.86

Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood. Lancet (1997) 1.84

Long-term risk of sarcoma following radiation treatment for breast cancer. Int J Radiat Oncol Biol Phys (1991) 1.77

Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study. J Clin Oncol (2002) 1.63

Psychological dysfunctions in lead-exposed workers. Relation to biological parameters of exposure. Scand J Work Environ Health (1978) 1.61

Two-stage treatment with preoperative endoscopic retrograde cholangiopancreatography (ERCP) compared with single-stage treatment with intraoperative ERCP for patients with symptomatic cholelithiasis with possible choledocholithiasis. Endoscopy (2006) 1.61

Results of a European randomized trial of Etanidazole combined with radiotherapy in head and neck carcinomas. Int J Radiat Oncol Biol Phys (1997) 1.60

Fecundability in relation to body mass and menstrual cycle patterns. Epidemiology (1999) 1.56

Can internal mammary chain treatment decrease the risk of death for patients with medial breast cancers and positive axillary lymph nodes? Cancer (1990) 1.55

High-dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: a phase II study. Bone Marrow Transplant (1992) 1.49

Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. J Clin Oncol (2001) 1.48

Measurement of the depth of maximum of extensive air showers above 10{18} eV. Phys Rev Lett (2010) 1.48

Frequency of seafood intake in pregnancy as a determinant of birth weight: evidence for a dose dependent relationship. J Epidemiol Community Health (1993) 1.46

Dural sinus thrombosis in children with cancer. Med Pediatr Oncol (1997) 1.45

Breast cancer and dieldrin. Lancet (2000) 1.40

Influence of smoking and alcohol consumption on blood lead levels. Int Arch Occup Environ Health (1981) 1.40

Evidence of increased chromosomal abnormalities in French Polynesian thyroid cancer patients. Eur J Nucl Med Mol Imaging (2004) 1.39

[Stereotaxic irradiation of 46 cerebral angiomas. Analysis of the angiographic results 2 and a half years after treatment]. Neurochirurgie (1991) 1.38

Antioxidative enzyme activities in human erythrocytes. Clin Chem (1997) 1.36

The ESTRO-QUALity assurance network (EQUAL). Radiother Oncol (2000) 1.34

Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood. Int J Cancer (1998) 1.32

Leukaemia mortality in French communes (administrative units) with a large and rapid population increase. Br J Cancer (1994) 1.29

Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma. Ann Neurol (1999) 1.29

Learning disabilities in children: significance of low-level lead-exposure and confounding factors. Acta Paediatr Scand (1990) 1.29

Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment. Br J Cancer (2003) 1.29

Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy. Br J Cancer (2004) 1.29

Simultaneous bacteriologic assessment of bile from gallbladder and common bile duct in control subjects and patients with gallstones and common duct stones. Arch Surg (1996) 1.29

Reactivity and repeatability of hygiene behaviour: structured observations from Burkina Faso. Soc Sci Med (1996) 1.29

Risk factors and classification of acute suppurative cholangitis. Br J Surg (1992) 1.28

Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: a multivariate analysis in 218 patients treated in a single institution. Bone Marrow Transplant (1999) 1.23

Extraskeletal mesenchymal chondrosarcoma. Radiology (1993) 1.22

Risks of brain tumour following treatment for cancer in childhood: modification by genetic factors, radiotherapy and chemotherapy. Int J Cancer (1998) 1.17

Decrease in phytochrome pelletability induced by green + far-red light in Trifolium repens. Biochem Biophys Res Commun (1981) 1.16

Musculoskeletal tumors: follow-up with MR imaging after treatment with surgery and radiation therapy. Radiology (1987) 1.15

Human exposure to nickel. IARC Sci Publ (1984) 1.15

Dirt and diarrhoea: formative research in hygiene promotion programmes. Health Policy Plan (1997) 1.14

Thyroid carcinomas after irradiation for a first cancer during childhood. Arch Intern Med (2000) 1.13

Lead concentration in deciduous teeth: variation related to tooth type and analytical technique. J Toxicol Environ Health (1986) 1.13

Evoked potentials in Faroese children prenatally exposed to methylmercury. Neurotoxicol Teratol (1999) 1.13

Benchmark dose calculations of methylmercury-associated neurobehavioural deficits. Toxicol Lett (2000) 1.12

Estimation of the radiation dose delivered to any point outside the target volume per patient treated with external beam radiotherapy. Radiother Oncol (1996) 1.12

Benchmark dose calculation from epidemiological data. Biometrics (2001) 1.11

Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography. J Clin Endocrinol Metab (2005) 1.11

Increased risk of second cancers following breast cancer: role of the initial treatment. Breast Cancer Res Treat (2000) 1.09

Repeated measurements of organochlorine exposure and breast cancer risk (Denmark). Cancer Causes Control (2000) 1.09

Haemochromatosis as a window into the study of the immunological system: a novel correlation between CD8+ lymphocytes and iron overload. Eur J Haematol (1994) 1.08

Methylmercury dose estimation from umbilical cord concentrations in patients with Minamata disease. Environ Res (1998) 1.08

Health implications for Faroe islanders of heavy metals and PCBs from pilot whales. Sci Total Environ (1996) 1.07

Feasibility and validity of three computer-assisted neurobehavioral tests in 7-year-old children. Neurotoxicol Teratol (1997) 1.06

Diet, living conditions and nasopharyngeal carcinoma in Tunisia--a case-control study. Int J Cancer (1990) 1.06

Clinical impact of dosimetry quality assurance programmes assessed by radiobiological modelling of data from the thermoluminescent dosimetry study of the European Organization for Research and Treatment of Cancer. Eur J Cancer (2000) 1.04

Delayed evoked potentials in children exposed to methylmercury from seafood. Neurotoxicol Teratol (1999) 1.04

Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment. Br J Cancer (1999) 1.04

Selection bias in determining the age dependence of waiting time to pregnancy. Am J Epidemiol (2000) 1.03

Diabetes and impaired fasting glucose in rural and urban populations in Futa Jallon (Guinea): prevalence and associated risk factors. Diabetes Metab (2007) 1.02

L-usnate-urease interactions: binding sites for the ligand. Z Naturforsch C (1981) 1.02

Risk of cancer and exposure to gasoline vapors. Am J Epidemiol (1997) 1.02

Characterization and radiosensitivity at high or low dose rate of four cell lines derived from human thyroid tumors. Int J Radiat Oncol Biol Phys (1997) 1.02

[Prevalence of the use of skin bleaching cosmetics in two areas in Dakar (Sénégal)]. Dakar Med (2000) 1.02

Relative impact of HLA phenotype and CD4-CD8 ratios on the clinical expression of hemochromatosis. Hepatology (1997) 1.02

Pulmonary evaluation of patients with osteosarcoma: roles of standard radiography, tomography, CT, scintigraphy, and tomoscintigraphy. AJR Am J Roentgenol (1984) 1.01

Toxicologic evidence of developmental neurotoxicity of environmental chemicals. Toxicology (2000) 1.01

Neurotoxic effects of heavy lead exposure determined with psychological tests. Toxicol Lett (1980) 1.01

Overexpression of GATA2 predicts an adverse prognosis for patients with acute myeloid leukemia and it is associated with distinct molecular abnormalities. Leukemia (2011) 1.01

Endogenous Inactivators of Arginase, l-Arginine Decarboxylase, and Agmatine Amidinohydrolase in Evernia prunastri Thallus. Plant Physiol (1983) 1.00

Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients. Cancer (1994) 1.00

Successful contracting of prevention services: fighting malnutrition in Senegal and Madagascar. Health Policy Plan (1999) 1.00

Dose finding and O6-alkylguanine-DNA alkyltransferase study of cisplatin combined with temozolomide in paediatric solid malignancies. Br J Cancer (2005) 0.98

[Acute esophageal necrosis: a retrospective case series]. Rev Esp Enferm Dig (2008) 0.98

Erythrocyte-Zn-protoporphyrin as an indicator of lead exposure. Scand J Clin Lab Invest (1978) 0.98

Occupational lead exposure in Denmark: screening with the haematofluorometer. Br J Ind Med (1979) 0.97

Occupational fluorosis through 50 years: clinical and epidemiological experiences. Am J Ind Med (1982) 0.97

Nonmetastatic intracranial germinoma: the experience of the French Society of Pediatric Oncology. Cancer (1997) 0.97

Trends in mercury in hair of Greenlandic polar bears (Ursus maritimus) during 1892-2001. Environ Sci Technol (2006) 0.96

Two forms of arginase in Evernia prunastri thallus. Biochem Biophys Res Commun (1982) 0.96

Organochlorine exposure and breast cancer survival. J Clin Epidemiol (2000) 0.96

bioNMF: a web-based tool for nonnegative matrix factorization in biology. Nucleic Acids Res (2008) 0.96

Prolonged breast-feeding: no association with increased risk of clinical malnutrition in young children in Burkina Faso. Bull World Health Organ (1993) 0.96

Consolidation with a busulfan-containing regimen followed by stem cell transplantation in infants with poor prognosis stage 4 neuroblastoma. Bone Marrow Transplant (2000) 0.96

Long-term follow up of 69 patients treated for optic pathway tumours before the chemotherapy era. Arch Dis Child (1998) 0.95

Methylmercury neurotoxicity independent of PCB exposure. Environ Health Perspect (1999) 0.95